UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review

Current pharmaceutical design, 2011-05, Vol.17 (14), p.1323-1332

2011

Volltextzugriff (PDF)

Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial

Addiction biology, 2014-09, Vol.19 (5), p.941-954

2014

Volltextzugriff (PDF)

Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments

Addiction biology, 2016-01, Vol.21 (1), p.171-182

2016

Volltextzugriff (PDF)

Commentary on Efficacy and Safety of Low dose ondansetron as a prospective precision medicine to treat alcohol use disorder phenotypes

European journal of internal medicine, 2024-09, Vol.127, p.36-38

Swift, Robert M.

2024

Volltextzugriff (PDF)

Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving

Addiction biology, 2012-03, Vol.17 (2), p.452-464

2012

Volltextzugriff (PDF)

Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial

BMJ open, 2023-01, Vol.13 (1), p.e066175-e066175

2023

Volltextzugriff (PDF)

Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial

Contemporary clinical trials communications, 2024-10, Vol.41, p.101333, Article 101333

2024

Volltextzugriff (PDF)

Contingent Vouchers and Motivational Interviewing for Cigarette Smokers in Residential Substance Abuse Treatment

Journal of substance abuse treatment, 2015-08, Vol.55, p.29-38

2015

Volltextzugriff (PDF)

Noradrenergic targets for the treatment of alcohol use disorder

Psychopharmacology, 2018-06, Vol.235 (6), p.1625-1634

2018

Volltextzugriff (PDF)

Moderators of Naltrexone's Effects on Drinking, Urge, and Alcohol Effects in Non-Treatment-Seeking Heavy Drinkers in the Natural Environment

Alcoholism, clinical and experimental research, 2008-01, Vol.32 (1), p.58-66

2008

Volltextzugriff (PDF)

Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence

Current pharmaceutical design, 2010-01, Vol.16 (19), p.2159-2181

2010

Volltextzugriff (PDF)

Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment

Journal of substance abuse treatment, 2014-03, Vol.46 (3), p.346-355

2014

Volltextzugriff (PDF)

Naltrexone and Nalmefene: Any Meaningful Difference?

Biological psychiatry (1969), 2013-04, Vol.73 (8), p.700-701

Swift, Robert M

2013

Volltextzugriff (PDF)

A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor

Addiction (Abingdon, England), 2017-06, Vol.112 (6), p.1025-1035

2017

Volltextzugriff (PDF)

Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease

Human psychopharmacology, 2011-12, Vol.26 (8), p.554-559

2011

Volltextzugriff (PDF)

Pharmacotherapy for alcohol use disorder: current and emerging therapies

Harvard review of psychiatry, 2015-03, Vol.23 (2), p.122-133

2015

Volltextzugriff (PDF)

Intravenous Ghrelin Administration Increases Alcohol Craving in Alcohol-Dependent Heavy Drinkers: A Preliminary Investigation

Biological psychiatry (1969), 2014-11, Vol.76 (9), p.734-741

2014

Volltextzugriff (PDF)

Altered sleep architecture following consecutive nights of presleep alcohol

Sleep (New York, N.Y.), 2024-04, Vol.47 (4), p.1

2024

Volltextzugriff (PDF)

Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters

Data in brief, 2017-12, Vol.15, p.407-413

2017

Volltextzugriff (PDF)

An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder

Psychopharmacology, 2022-01, Vol.239 (1), p.35-46

2022

Volltextzugriff (PDF)

Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms

Addiction (Abingdon, England), 2017-10, Vol.112 (10), p.1808-1820

2017

Volltextzugriff (PDF)

Typologies of Alcohol Dependence. From Jellinek to Genetics and Beyond

Neuropsychology review, 2009-03, Vol.19 (1), p.115-129

2009

Volltextzugriff (PDF)

Topiramate for treating alcohol dependence: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2007-10, Vol.298 (14), p.1641

2007

Volltextzugriff (PDF)

Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness

Nicotine & tobacco research, 2019-12, Vol.21 (Supplement_1), p.S38-S45

2019

Volltextzugriff (PDF)

Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study

Neuropharmacology, 2019-11, Vol.158, p.107711-107711, Article 107711

2019

Volltextzugriff (PDF)

1 – 25 von 536

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(486)
Mit Volltextzugriff
(432)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(536)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review

Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial

Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments

Commentary on Efficacy and Safety of Low dose ondansetron as a prospective precision medicine to treat alcohol use disorder phenotypes

Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving

Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial

Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial

Contingent Vouchers and Motivational Interviewing for Cigarette Smokers in Residential Substance Abuse Treatment

Noradrenergic targets for the treatment of alcohol use disorder

Moderators of Naltrexone's Effects on Drinking, Urge, and Alcohol Effects in Non-Treatment-Seeking Heavy Drinkers in the Natural Environment

Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence

Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment

Naltrexone and Nalmefene: Any Meaningful Difference?

A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor

Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease

Pharmacotherapy for alcohol use disorder: current and emerging therapies

Intravenous Ghrelin Administration Increases Alcohol Craving in Alcohol-Dependent Heavy Drinkers: A Preliminary Investigation

Altered sleep architecture following consecutive nights of presleep alcohol

Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters

An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder

Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms

Typologies of Alcohol Dependence. From Jellinek to Genetics and Beyond

Topiramate for treating alcohol dependence: a randomized controlled trial

Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness

Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study

Suchergebnisse filtern